Aptahem AB
A clinical-stage biotech developing aptamer-based drugs for life-threatening conditions.
APTA | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0022447173 (+2 more)
- LEI:
- 549300IVD1BY4CJMSO40
- Country:
- Sweden
- Address:
- Norra Vallgatan 58, 211 22 Malmö
- Website:
- https://aptahem.com/
Description
Aptahem AB is a clinical-stage biotechnology company focused on developing aptamer-based pharmaceuticals for acute, life-threatening conditions. The company's technology utilizes aptamers, which are synthetic RNA-based molecules that can serve as an alternative to antibodies. Its lead candidate, Apta-1, is in clinical development for the treatment of sepsis and other critical inflammatory conditions involving a combination of coagulation, inflammation, and tissue damage. Apta-1 is designed with a multi-mechanistic profile to address the complex pathophysiology of these diseases, targeting a significant unmet medical need for which there are currently no effective specific treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Aptahem AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Aptahem AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Aptahem AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
